Evidence map›Paper›PMID 31131209›Full record

ArticleInternational journal of spine surgery2019

Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain: 2-Year Results From a Prospective Randomized Double-Blind Sham-Controlled Multicenter Study.

Jeffrey S Fischgrund, Alfred Rhyne, Jörg Franke, Rick Sasso, Scott Kitchel, Hyun Bae, Christopher Yeung, Eeric Truumees, Michael Schaufele, Philip Yuan and 5 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in International journal of spine surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05660512 (A Prospective Single Arm Cohort Study of Intraosseous Basivertebral Nerve Ablation), which is not on this map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05660512 active not recruitingnot on this mapstarted 2020, after this paper: background citation

A Prospective Single Arm Cohort Study of Intraosseous Basivertebral Nerve Ablation

TypeobservationalSponsorUniversity of UtahRan2020 to 2026Enrolled150ConditionsLow Back PainArmsIntracept Procedure
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2020
    Trial
  4. A prospective, open-label, single-arm, multi-center study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2019
    Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Association between MRI findings and inflammatory symptoms in non-specific chronic low back pain.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 14 institutions in 2 countries.

Jeffrey S FischgrundDepartment of Orthopedic Surgery, Oakland University, William Beaumont School of Medicine, Royal Oak, Michigan.
Alfred RhyneOrthoCarolina Spine Center, Charlotte, North Carolina.
Jörg FrankeDepartment of Orthopedics-Spine and Pediatric Orthopedics, Klinikum Magdeburg gGmbH, Magdeburg, Germany.
Rick SassoDepartment of Orthopedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
Scott KitchelNeuroSpine Institute, Eugene, Oregon.
Hyun BaeDepartment of Surgery, Cedars Sinai Medical Center, Los Angeles, California.
Christopher YeungDesert Institute for Spine Care, Phoenix, Arizona.
Eeric TruumeesSeton Brain & Spine Institute, Department of Surgery, Dell Medical School, Seton Spine & Scoliosis Center, Austin, Texas.
Michael SchaufelePain Solutions Treatment Centers, Marietta, Georgia.
Philip YuanDepartment of Surgery, Long Beach Memorial Medical Center, Long Beach, California.
Peter VajkoczyDepartment of Neurosugery, Charité Universitätsmedizin, Berlin Campus, Virchow Medical Center, Berlin, Germany.
Michael DepalmaVirginia iSpine Physicians, Richmond, Virginia.
David G AndersonDepartment of Orthopaedic and Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lee ThibodeauMaine Spine Surgery, Portland, Maine.
Bernhard MeyerDirektor der Neurochirurgische Klinik und Poliklinik, Technischen Universität München, Klinikum rechts der Isar, Munich, Germany.
Cedars-Sinai Medical Center · USCharité - Universitätsmedizin Berlin · DEDesert Institute For Spine Care · USIndiana University – Purdue University Indianapolis · USKlinikum Magdeburg · DEKlinikum rechts der Isar · DELong Beach Memorial Medical Center · USNeurological Surgery · USNeuroSpine Institute · USOakland University · USOrthoCarolina · USPain Management Centers Of America · USSeton Medical Center · USVirginia Spine Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of the present study is to report the 2-year clinical outcomes for chronic low back pain (CLBP) patients treated with radiofrequency (RF) ablation of the basivertebral nerve (BVN) in a randomized controlled trial that previously reported 1-year follow up.

methodsA total of 147 patients were treated with RF ablation of the BVN in a randomized controlled trial designed to demonstrate safety and efficacy as part of a Food and Drug Administration-Investigational Device Exemption trial. Evaluations, including patient self-assessments, physical and neurological examinations, and safety assessments, were performed at 2 and 6 weeks, and 3, 6, 12, 18, and 24 months postoperatively. Participants randomized to the sham control arm were allowed to cross to RF ablation at 12 months. Due to a high rate of crossover, RF ablation treated participants acted as their own control in a comparison to baseline for the 24-month outcomes.

resultsClinical improvements in the Oswestry Disability Index (ODI), Visual Analog Scale (VAS), and the Medical Outcomes Trust Short-Form Health Survey Physical Component Summary were statistically significant compared to baseline at all follow-up time points through 2 years. The mean percent improvements in ODI and VAS compared to baseline at 2 years were 53.7 and 52.9%, respectively. Responder rates for ODI and VAS were also maintained through 2 years with patients showing clinically meaningful improvements in both: ODI ≥ 10-point improvement in 76.4% of patients and ODI ≥ 20-point improvement in 57.5%; VAS ≥ 1.5 cm improvement in 70.2% of patients.

conclusionsPatients treated with RF ablation of the BVN for CLBP exhibited sustained clinical benefits in ODI and VAS and maintained high responder rates at 2 years following treatment. Basivertebral nerve ablation appears to be a durable, minimally invasive treatment for the relief of CLBP.

Indexed as

basivertebral nervechronic low back painradiofrequency ablation

Identifiers

PMID31131209
PMCPMC6510180
OpenAlexW2930090799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.